Showing 1 - 10 of 318
We investigate behavioral responses to a staggered disruption in the supply of prescription opioids across U.S. states: the introduction of electronic Prescription Drug Monitoring Programs (PDMPs). Using administrative datasets, we find PDMPs curtail the proliferation of prescription opioids....
Persistent link: https://www.econbiz.de/10013177127
We analyse the effect of competition on quality in hospital markets with regulated prices, considering both the effect of (i) introducing competition (monopoly versus competition) and (ii) increasing competition through lower transportation costs (increased substitutability) or a higher number...
Persistent link: https://www.econbiz.de/10003850156
A famous idea to maintain affordable health expenditures is to cut back statutory health insurance (SHI) to a basic insurance and to introduce supplementary private health insurance (PHI), permitted to cover the remaining benefits and to apply managed care mechanisms. The measure is supposed to...
Persistent link: https://www.econbiz.de/10003872288
This paper investigates competition between health insurance companies under different financing regulations. We consider two alternatives advanced in recent German health care reform discussions: competition by contribution rates (health contributions) and by fees (health premia). We find that...
Persistent link: https://www.econbiz.de/10008698408
In Scandinavia, the provision of health care services has been, almost entirely, the responsibility of the public health care system. However, in the last five to seven years there has been remarkable growth in the private health care market. These health care services are obtained normally...
Persistent link: https://www.econbiz.de/10003965860
market entry is possible, a budget can be efficiency enhancing, if in addition a price floor is used. …
Persistent link: https://www.econbiz.de/10011398025
We consider an economy where most of the health care is publicly provided,and where there is waiting time for several types of treatments. Privatehealth care without waiting time is an option for the patients in the publichealth queue. We show that although patients with low waiting costs...
Persistent link: https://www.econbiz.de/10011400300
This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a … theory model where the producer price is subject to bargaining between the brand-name producer and a distributor, we show … that the effects of stricter price regulation crucially depend on whether the producer faces competition from parallel …
Persistent link: https://www.econbiz.de/10011305382
Many countries have reformed hospital reimbursement policies to provide stronger incentives for quality and cost reduction. The purpose of this work is to understand how the effect of such reforms depends on the intensity of local competition. We build a nonprice competition model to examine the...
Persistent link: https://www.econbiz.de/10009765047
Since 2003 German hospitals are reimbursed according to diagnosis related groups (DRGs). Patient classification in neonatology is based inter alia on birth weight, with substantial discontinuities in reimbursement at eight different thresholds. These discontinuities create strong incentives to...
Persistent link: https://www.econbiz.de/10009772916